The University of Iowa Carver College of Medicine actively brings innovative technologies, ideas, and procedures to the marketplace. The intellectual property and laboratory discoveries generated by the research enterprise have led to many successful partnerships, both private and public, as well as several venture opportunities and commercial start-ups.
The pursuit of innovation by college researchers continues to meet the needs of the rapidly evolving live science sector, including significant contributions to the fields of diagnostic imaging, drug development and delivery, and genetically inherited diseases. In fact, over the past several decades, the Carver College of Medicine has fostered the launch of 27 new commercial start-ups—approximately four per year—based on research and/or technology developed by college faculty, staff, and students. Also, the Carver College of Medicine is responsible for 216 active domestic and 278 active foreign patents.
Though the Carver College of Medicine remains focused on building the research and technology base here in Iowa, the college's impact is global.
Innovations Optioned or Licensed
Innovation Financing (millions)
Innovation financing includes state funding, research grants, competitions, small business innovation research and small business technology transfer funding, seed/angel funding, as well as series A, B, and C funding. *2012 to present are reported by calendar year rather fiscal year. FY12 figures include funding from January to July 2012. CY12 figures only include funding from July-December 2012. **CY13 figures include funding from January to September 2013.